Nicola Perrotta

4PUBLICATIONS
0CO-AUTHORS
Economic models and forecastingBehavioural epidemiologyInfant and child healthEnvironmentally sustainable engineering
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jul 22, 2026
Pharmacoeconomic Analysis of Osimertinib Compared to Earlier-Generation EGFR Inhibitors in EGFR-Mutated NSCLC: A Systematic Review.

|Jan 24, 2026
Long-term impact of Elexacaftor/Tezacaftor/ivacaftor on pulmonary, nutritional and metabolic outcomes in homozygous F508del cystic fibrosis patients: A real-world cohort study.

Nicola Perrotta, Luigi Angelo Fiorito, Roberta Vescovo

|Oct 03, 2025
Real-World Evaluation of Outcomes and Safety of Elexacaftor/Tezacaftor/Ivacaftor in Pediatric Patients With Cystic Fibrosis: A Retrospective Study.

Nicola Perrotta, Luigi Angelo Fiorito, Rossella Gentile

|Apr 03, 2025
Improved Clinical Outcomes With Elexacaftor/Tezacaftor/Ivacaftor in Patients With Cystic Fibrosis and Advanced Lung Disease: Real-World Evidence From an Italian Single-Center Study.

Nicola Perrotta, Luigi Angelo Fiorito, Gianfranco Casini

Pageof 1

Frequent Collaborators